Home > Financial Ratios > LACTOSE (INDIA)

LACTOSE (INDIA)
Core EBITDA Margin

    Back to All Ratios
COMMUNITY POLL
for LACTOSE (INDIA)
Please provide your vote to see the results

LACTOSE (INDIA) Last 5 Year Core EBITDA Margin History

[Standalone]

Mar2025Mar2024Mar2023Mar2022Mar2021
   Core EBITDA Margin(%) 14.4916.6717.2926.6917.80

What is the latest Core EBITDA Margin ratio of LACTOSE (INDIA) ?

The latest Core EBITDA Margin ratio of LACTOSE (INDIA) is 14.49 based on Mar2025 Standalone results.
Year Core EBITDA Margin
Mar202514.49
Mar202416.67
Mar202317.29
Mar202226.69
Mar202117.80

How is Core EBITDA Margin of LACTOSE (INDIA) Trending?

Years Core EBITDA Margin % Change
Mar2025 14.49
-13.08
Mar2024 16.67
-3.59
Mar2023 17.29
-35.22
Mar2022 26.69
49.94
Mar2021 17.8 -

Other Financial Ratios of LACTOSE (INDIA)


Compare Core EBITDA Margin ratio of peers of LACTOSE (INDIA)

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
LACTOSE (INDIA) ₹144.9 Cr 6.2% -2.6% -39.2% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹421,419.0 Cr 3.5% 6.2% -4.2% Stock Analytics
DIVIS LABORATORIES ₹172,857.0 Cr -2.7% -0.7% 11% Stock Analytics
TORRENT PHARMACEUTICALS ₹129,953.0 Cr 0.6% 9.1% 19.7% Stock Analytics
CIPLA ₹123,722.0 Cr 1.2% -1.4% -4.1% Stock Analytics
DR REDDYS LABORATORIES ₹103,906.0 Cr 3.9% 0.6% -3.7% Stock Analytics


LACTOSE (INDIA) Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
LACTOSE (INDIA)

6.2%

-2.6%

-39.2%

SENSEX

1.6%

2.7%

6.3%


You may also like the below Video Courses